• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

子宫内膜增生

Endometrial Hyperplasia.

作者信息

Ring Kari L, Mills Anne M, Modesitt Susan C

机构信息

Gynecologic Oncology Division, Department of Obstetrics and Gynecology, and the Department of Pathology, University of Virginia Health System, Charlottesville, Virginia; and the Gynecologic Oncology Division, Gynecology and Obstetrics Department, Emory University, Atlanta, Georgia.

出版信息

Obstet Gynecol. 2022 Dec 1;140(6):1061-1075. doi: 10.1097/AOG.0000000000004989. Epub 2022 Nov 2.

DOI:10.1097/AOG.0000000000004989
PMID:36357974
Abstract

The objectives of this Clinical Expert Series on endometrial hyperplasia are to review the etiology and risk factors, histologic classification and subtypes, malignant progression risks, prevention options, and to outline both surgical and nonsurgical treatment options. Abnormal uterine and postmenopausal bleeding remain the hallmark of endometrial pathology, and up to 10-20% of postmenopausal bleeding will be either hyperplasia or cancer; thus, immediate evaluation of any abnormal bleeding with either tissue procurement for pathology or imaging should be undertaken. Although anyone with a uterus may develop atypical hyperplasia, also known as endometrial intraepithelial neoplasia (EIN), genetic predispositions (eg, Lynch syndrome), obesity, chronic anovulation, and polycystic ovarian syndrome all markedly increase these risks, whereas use of oral contraceptive pills or progesterone-containing intrauterine devices will decrease the risk. An EIN diagnosis carries a high risk of concomitant endometrial cancer or eventual progression to cancer in the absence of treatment. The definitive and curative treatment for EIN remains hysterectomy; however, the obesity epidemic, the potential desire for fertility-sparing treatments, the recognition of varying rates of malignant transformation, medical comorbidities, and an aging population all may factor into decisions to employ nonsurgical treatment modalities.

摘要

本子宫内膜增生临床专家系列的目标是回顾其病因和危险因素、组织学分类及亚型、恶性进展风险、预防方法,并概述手术和非手术治疗方案。子宫异常出血和绝经后出血仍然是子宫内膜病变的标志,高达10%-20%的绝经后出血将是增生或癌症;因此,应立即通过获取病理组织或影像学检查对任何异常出血进行评估。虽然任何有子宫的人都可能发生非典型增生,也称为子宫内膜上皮内瘤变(EIN),但遗传易感性(如林奇综合征)、肥胖、慢性无排卵和多囊卵巢综合征都会显著增加这些风险,而使用口服避孕药或含孕激素的宫内节育器会降低风险。未经治疗的EIN诊断伴有子宫内膜癌或最终进展为癌症的高风险。EIN的确定性和根治性治疗仍然是子宫切除术;然而,肥胖流行、保留生育功能治疗的潜在需求、对不同恶性转化率的认识、内科合并症以及人口老龄化都可能影响采用非手术治疗方式的决策。

相似文献

1
Endometrial Hyperplasia.子宫内膜增生
Obstet Gynecol. 2022 Dec 1;140(6):1061-1075. doi: 10.1097/AOG.0000000000004989. Epub 2022 Nov 2.
2
Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms.异常子宫出血女性的子宫内膜癌和子宫内膜上皮内瘤变风险评估及其对临床管理算法的影响。
Am J Obstet Gynecol. 2020 Oct;223(4):549.e1-549.e13. doi: 10.1016/j.ajog.2020.03.032. Epub 2020 Apr 5.
3
Risk Factors for Endometrial Cancer or Hyperplasia in Adolescents and Women 25 Years Old or Younger.青少年及25岁及以下女性子宫内膜癌或子宫内膜增生的风险因素
J Pediatr Adolesc Gynecol. 2019 Oct;32(5):546-549. doi: 10.1016/j.jpag.2019.06.004. Epub 2019 Jun 18.
4
Current management of endometrial hyperplasia and endometrial intraepithelial neoplasia (EIN).子宫内膜增生和子宫内膜上皮内瘤变(EIN)的当前管理。
Eur J Gynaecol Oncol. 2009;30(4):396-401.
5
Body mass index trumps age in decision for endometrial biopsy: cohort study of symptomatic premenopausal women.体重指数在决定是否进行子宫内膜活检方面比年龄更具影响力:有症状的绝经前女性队列研究
Am J Obstet Gynecol. 2016 Nov;215(5):598.e1-598.e8. doi: 10.1016/j.ajog.2016.06.006. Epub 2016 Jun 8.
6
Should body mass index replace age to drive the decision for endometrial sampling in premenopausal women with abnormal uterine bleeding?绝经前异常子宫出血的女性,是否应该用体重指数替代年龄来决定是否进行子宫内膜取样?
Gynecol Endocrinol. 2022 May;38(5):432-437. doi: 10.1080/09513590.2022.2058484. Epub 2022 Apr 20.
7
Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5.子宫内膜上皮内瘤变或不典型子宫内膜增生的管理:ACOG 临床共识 No.5。
Obstet Gynecol. 2023 Sep 1;142(3):735-744. doi: 10.1097/AOG.0000000000005297.
8
Risk of More Advanced Lesions at Hysterectomy after Initial Diagnosis of Non-Atypical Endometrial Hyperplasia in Patients with Postmenopausal Bleeding and Oral Anticoagulant Treatment.绝经后出血且接受口服抗凝治疗的患者中,初次诊断为非典型子宫内膜增生后行子宫切除术时发生更高级别病变的风险。
Medicina (Kaunas). 2021 Sep 23;57(10):1003. doi: 10.3390/medicina57101003.
9
Management of endometrial precancers.子宫内膜癌前病变的管理。
Obstet Gynecol. 2012 Nov;120(5):1160-75. doi: 10.1097/aog.0b013e31826bb121.
10
Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia.异常子宫出血的管理与子宫内膜增生的病理学
Obstet Gynecol Clin North Am. 2007 Dec;34(4):717-37, ix. doi: 10.1016/j.ogc.2007.09.001.

引用本文的文献

1
A Machine Learning Model Integrating Preoperative Blood-Based Indices for Early and Noninvasive Detection of Endometrial Cancer.一种整合术前血液指标的机器学习模型用于子宫内膜癌的早期无创检测
J Inflamm Res. 2025 Aug 12;18:10873-10884. doi: 10.2147/JIR.S530974. eCollection 2025.
2
Human Epididymis Protein 4 Predicted Concurrent Intermediate-high-risk Endometrial Cancer and Eligibility of Fertility-sparing Treatment for Patients Diagnosed with Endometrial Atypical Hyperplasia Before Surgery.人附睾蛋白4预测同时存在的中高危子宫内膜癌及术前诊断为子宫内膜非典型增生患者保留生育功能治疗的适用性。
Int J Med Sci. 2025 Jul 11;22(13):3292-3303. doi: 10.7150/ijms.115170. eCollection 2025.
3
Multi-omics analysis revealed the addiction to glutamine and susceptibility to de novo lipogenesis of endometrial neoplasm.
多组学分析揭示了子宫内膜肿瘤对谷氨酰胺的依赖以及对从头脂肪生成的易感性。
Sci China Life Sci. 2025 Jul 24. doi: 10.1007/s11427-024-2761-y.
4
Tissue-Based Metabolomic Profiling of Endometrial Cancer and Hyperplasia.子宫内膜癌和子宫内膜增生的组织代谢组学分析
Metabolites. 2025 Jul 5;15(7):458. doi: 10.3390/metabo15070458.
5
Genetic Polymorphisms in Base Excision Repair (BER) and Nucleotide Excision Repair (NER) Pathways as Potential Biomarkers for Gynecological Cancers: A Comprehensive Literature Review.碱基切除修复(BER)和核苷酸切除修复(NER)途径中的基因多态性作为妇科癌症的潜在生物标志物:一项综合文献综述
Cancers (Basel). 2025 Jun 27;17(13):2170. doi: 10.3390/cancers17132170.
6
Dietary factors and postmenopausal bleeding: A Mendelian randomization investigation.饮食因素与绝经后出血:一项孟德尔随机化研究。
Medicine (Baltimore). 2025 May 30;104(22):e41650. doi: 10.1097/MD.0000000000041650.
7
Impact of endocrine disrupting chemicals (EDCs) on epigenetic regulation in the uterus: a narrative review.内分泌干扰化学物质(EDCs)对子宫表观遗传调控的影响:一项叙述性综述。
Reprod Biol Endocrinol. 2025 May 26;23(1):80. doi: 10.1186/s12958-025-01413-z.
8
Endocrine therapy for endometrial cancer: traditional approaches and novel targets.子宫内膜癌的内分泌治疗:传统方法与新靶点
Front Oncol. 2025 May 5;15:1570011. doi: 10.3389/fonc.2025.1570011. eCollection 2025.
9
Advancement in early diagnosis of polycystic ovary syndrome: biomarker-driven innovative diagnostic sensor.多囊卵巢综合征早期诊断的进展:基于生物标志物的创新诊断传感器。
Mikrochim Acta. 2025 May 1;192(5):331. doi: 10.1007/s00604-025-07187-w.
10
The association of molecular classification with fertility-sparing treatment of atypical endometrial hyperplasia and endometrial cancer: a retrospective study.分子分类与非典型子宫内膜增生和子宫内膜癌保留生育功能治疗的相关性:一项回顾性研究。
Front Oncol. 2025 Apr 15;15:1506639. doi: 10.3389/fonc.2025.1506639. eCollection 2025.